Targeting TP53 disruption in chronic lymphocytic leukemia: Current strategies and future directions.

导出 LinkOut

翻译打印收藏纠错

作者： Stefano,Molica ^[1] ; Constantine,Tam ^[2] ; David,Allsup ^[3] ; Aaron,Polliack ^[4]

作者单位： Queens Centre for Oncology and Haematology, Castle Hill Hospital, Hull University NHS Trust, Hull, UK. ^[1] Alfred Hospital, Melbourne, Victoria, Australia. ^[2] Centre of Biomedicine, Hull York Medical School, University of Hull, Hull, UK. ^[3] Department of Hematology, Hadassah Hebrew University Medical Center, Jerusalem, Israel. ^[4]

关键词 CLL current strategies novel therapies targeting TP53 aberrations

主题词人类(Humans);动物(Animals);小鼠(Mice);肿瘤抑制蛋白质p53(Tumor Suppressor Protein p53);白血病, 淋巴细胞, 慢性, B细胞(Leukemia, Lymphocytic, Chronic, B-Cell);抗肿瘤药(Antineoplastic Agents)

DOI 10.1002/hon.3238

PMID 37937506

发布时间 2024-01-31

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交